Effects of pretreatment with ketoprofen and phenylbutazone on experimentally induced synovitis in horses. 1996

J G Owens, and S G Kamerling, and S R Stanton, and M L Keowen, and J S Prescott-Mathews
Department of Veterinary Physiology, Pharmacology, and Toxicology, School of Veterinary Medicine, Louisiana State University, Baton Rouge 70803, USA.

OBJECTIVE To compare the analgesic and anti-inflammatory effects of the nonsteroidal anti-inflammatory drugs (NSAID), ketoprofen (2.20 and 3.63 mg/kg of body weight) and phenylbutazone (4.40 mg/kg), in an acute equine synovitis model. METHODS 4 groups of 6 horses received NSAID or saline solution in a randomized design. METHODS 24 clinically normal mares and geldings. METHODS Left intercarpal joints were injected with sterile carrageenan to induce synovitis at the same time as IV administration of NSAID or saline solution. Clinical assessments were made and synovial fluid was withdrawn at 0, 1, 3, 6, 9, 12, 24, and 48 hours. RESULTS The eicosanoids, prostaglandin E2 (PGE2) and leukotriene B4, increased in synovial fluid after synovitis induction in all horses then returned to near baseline by 48 hours. All NSAID-treated horses had decreased PGE2, compared with saline-treated horses. This effect lasted longer in phenylbutazone-treated horses than in ketoprofen-treated horses. There were no treatment effects on leukotriene B4. In saline-treated animals, lameness, joint temperature, and synovial fluid volume, protein concentration, and nucleated cells increased 3 to 12 hours after induction, with marked reduction by 48 hours. Only phenylbutazone treatment reduced lameness, joint temperature, and synovial fluid volume. CONCLUSIONS Phenylbutazone was more effective than ketoprofen in reducing lameness, joint temperature, synovial fluid volume, and synovial fluid PGE2. Results do not support lipoxygenase inhibition by either NSAID. CONCLUSIONS This reversible model induced synovial fluid alterations similar to those observed in horses with septic arthritis. Results indicate that phenylbutazone may be more useful than ketoprofen in treating acute joint inflammation.

UI MeSH Term Description Entries
D007596 Joints Also known as articulations, these are points of connection between the ends of certain separate bones, or where the borders of other bones are juxtaposed. Joint
D007660 Ketoprofen An IBUPROFEN-type anti-inflammatory analgesic and antipyretic. It is used in the treatment of rheumatoid arthritis and osteoarthritis. Benzoylhydratropic Acid,19,583 RP,2-(3-Benzoylphenyl)propionic Acid,Alrheumat,Alrheumum,Orudis,Profenid,RP-19583,RP 19583,RP, 19,583,RP19583
D007794 Lameness, Animal A departure from the normal gait in animals. Gait Disorders, Animal,Animal Gait Disorder,Animal Gait Disorders,Animal Lameness,Animal Lamenesses,Disorder, Animal Gait,Disorders, Animal Gait,Gait Disorder, Animal,Lamenesses, Animal
D007975 Leukotriene B4 The major metabolite in neutrophil polymorphonuclear leukocytes. It stimulates polymorphonuclear cell function (degranulation, formation of oxygen-centered free radicals, arachidonic acid release, and metabolism). (From Dictionary of Prostaglandins and Related Compounds, 1990) 5,12-HETE,5,12-diHETE,LTB4,Leukotriene B,Leukotriene B-4,Leukotrienes B,5,12 HETE,5,12 diHETE,B-4, Leukotriene,Leukotriene B 4
D008297 Male Males
D010653 Phenylbutazone A butyl-diphenyl-pyrazolidinedione that has anti-inflammatory, antipyretic, and analgesic activities. It has been used in ANKYLOSING SPONDYLITIS; RHEUMATOID ARTHRITIS; and REACTIVE ARTHRITIS. Diphenylbutazone,Fenilbutazon,Butacote,Butadion,Butadione,Butapirazol,Butapyrazole,Butazolidin
D011506 Proteins Linear POLYPEPTIDES that are synthesized on RIBOSOMES and may be further modified, crosslinked, cleaved, or assembled into complex proteins with several subunits. The specific sequence of AMINO ACIDS determines the shape the polypeptide will take, during PROTEIN FOLDING, and the function of the protein. Gene Products, Protein,Gene Proteins,Protein,Protein Gene Products,Proteins, Gene
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D005260 Female Females

Related Publications

J G Owens, and S G Kamerling, and S R Stanton, and M L Keowen, and J S Prescott-Mathews
January 1993, Journal of the American Veterinary Medical Association,
J G Owens, and S G Kamerling, and S R Stanton, and M L Keowen, and J S Prescott-Mathews
January 2010, American journal of veterinary research,
J G Owens, and S G Kamerling, and S R Stanton, and M L Keowen, and J S Prescott-Mathews
August 2014, American journal of veterinary research,
J G Owens, and S G Kamerling, and S R Stanton, and M L Keowen, and J S Prescott-Mathews
April 2018, Journal of veterinary pharmacology and therapeutics,
J G Owens, and S G Kamerling, and S R Stanton, and M L Keowen, and J S Prescott-Mathews
June 2001, Journal of veterinary pharmacology and therapeutics,
J G Owens, and S G Kamerling, and S R Stanton, and M L Keowen, and J S Prescott-Mathews
March 2010, Veterinary anaesthesia and analgesia,
J G Owens, and S G Kamerling, and S R Stanton, and M L Keowen, and J S Prescott-Mathews
May 2009, Veterinary anaesthesia and analgesia,
J G Owens, and S G Kamerling, and S R Stanton, and M L Keowen, and J S Prescott-Mathews
September 2011, American journal of veterinary research,
J G Owens, and S G Kamerling, and S R Stanton, and M L Keowen, and J S Prescott-Mathews
July 2017, Equine veterinary journal,
J G Owens, and S G Kamerling, and S R Stanton, and M L Keowen, and J S Prescott-Mathews
August 2009, American journal of veterinary research,
Copied contents to your clipboard!